A Randomized, Investigator And Subject-Blind, Sponsor-Open, Placebo-Controlled Study To Examine The Effects Of PF-04360365 On ABETA In Patients With Alzheimer's Disease And Healthy Volunteers.
Phase of Trial: Phase I
Latest Information Update: 25 Sep 2012
At a glance
- Drugs Ponezumab (Primary)
- Indications Alzheimer's disease
- Focus Pharmacodynamics
- Sponsors Pfizer
- 10 Jun 2017 Biomarkers information updated
- 01 Sep 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 16 Mar 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.